Search research articles
Contact Us
Filters
Showing results (31-40 of 101) with videos related to
Page
of 11
Sort By:
Clinical Case Reports
|
December 22, 2021
Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature
Mizba Baksh, Liuyan Jiang, Unnati Bhatia, et al.
Cancer
|
November 14, 2015
Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis
Sikander Ailawadhi, Pooja Advani, Dongyun Yang, et al.
Leukemia & Lymphoma
|
November 17, 2006
Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism
Kena C Miller, Swaminathan Padmanabhan, Laurie Dimicelli, et al.
Chemical Biology & Drug Design
|
April 10, 2015
Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15
Xin Wang, Pádraig D'Arcy, Thomas R Caulfield, et al.
Leukemia & Lymphoma
|
December 29, 2004
Arterial thrombosis in four patients treated with thalidomide
Sarah L Scarpace, Theresa Hahn, Hilary Roy, et al.
HIV Clinical Trials
|
May 29, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS
Zale P Bernstein, Stephen P Brooks, Asher Chanan-Khan, et al.
British Journal of Haematology
|
October 12, 2013
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma
Jonathan L Kaufman, Ruben Niesvizky, Edward A Stadtmauer, et al.
Clinical Case Reports
|
February 10, 2022
Myelomatous ascites and pleural effusion in relapsed multiple myeloma
Mizba Baksh, Ke Li, Liuyan Jiang, et al.
Leukemia & Lymphoma
|
September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma
Asher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Molecular Cancer Research : MCR
|
May 3, 2012
The proteasome activator PA200 regulates tumor cell responsiveness to glutamine and resistance to ionizing radiation
Jennifer Blickwedehl, Scott Olejniczak, Ryan Cummings, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 101) with videos related to
Sort By:
Page
of 11
Clinical Case Reports
|
December 22, 2021
Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature
Mizba Baksh, Liuyan Jiang, Unnati Bhatia, et al.
Cancer
|
November 14, 2015
Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis
Sikander Ailawadhi, Pooja Advani, Dongyun Yang, et al.
Leukemia & Lymphoma
|
November 17, 2006
Prospective evaluation of low-dose warfarin for prevention of thalidomide associated venous thromboembolism
Kena C Miller, Swaminathan Padmanabhan, Laurie Dimicelli, et al.
Chemical Biology & Drug Design
|
April 10, 2015
Synthesis and evaluation of derivatives of the proteasome deubiquitinase inhibitor b-AP15
Xin Wang, Pádraig D'Arcy, Thomas R Caulfield, et al.
Leukemia & Lymphoma
|
December 29, 2004
Arterial thrombosis in four patients treated with thalidomide
Sarah L Scarpace, Theresa Hahn, Hilary Roy, et al.
HIV Clinical Trials
|
May 29, 2002
Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores allostimulatory function to accessory cells in patients with AIDS
Zale P Bernstein, Stephen P Brooks, Asher Chanan-Khan, et al.
British Journal of Haematology
|
October 12, 2013
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma
Jonathan L Kaufman, Ruben Niesvizky, Edward A Stadtmauer, et al.
Clinical Case Reports
|
February 10, 2022
Myelomatous ascites and pleural effusion in relapsed multiple myeloma
Mizba Baksh, Ke Li, Liuyan Jiang, et al.
Leukemia & Lymphoma
|
September 17, 2004
Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma
Asher Chanan-Khan, Tariq Islam, Arif Alam, et al.
Molecular Cancer Research : MCR
|
May 3, 2012
The proteasome activator PA200 regulates tumor cell responsiveness to glutamine and resistance to ionizing radiation
Jennifer Blickwedehl, Scott Olejniczak, Ryan Cummings, et al.
Page
of 11